BioMarin Pharmaceutical(BMRN) - 2023 Q2 - Quarterly Report

Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 BMRN The Nasdaq Global Select Market ______________________________________ Form 10-Q Commission File Number: 000-26727 ______________________________________ BioMarin Pharmaceutical Inc. (Exact name of registrant as specified in its charter) ______________________________________ Delaware 68-0397820 (State or other jurisdiction of incorpo ...